{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:31:49Z","timestamp":1792171909778,"version":"4.4.0"},"reference-count":150,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1210\/jc.2018-02548","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T21:36:29Z","timestamp":1550698589000},"page":"2875-2891","source":"Crossref","is-referenced-by-count":125,"title":["Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7336-7610","authenticated-orcid":false,"given":"Enrico","family":"Carmina","sequence":"first","affiliation":[{"name":"Department of Health Sciences and Mother and Child Care, University of Palermo, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[{"name":"Department of Health Policy, Management, and Behavior, School of Public Health, University at Albany, State University of New York, Albany, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Bergfeld","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cleveland Clinic, Cleveland, Ohio"},{"name":"Department of Pathology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6890-1644","authenticated-orcid":false,"given":"H\u00e9ctor F","family":"Escobar-Morreale","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Hospital Universitario Ram\u00f3n y Cajal, Universidad de Alcal\u00e1, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas, Madrid Spain"},{"name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Futterweit","sequence":"additional","affiliation":[{"name":"Mount Sinai School of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Huddleston","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University of California at San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogerio","family":"Lobo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University Medical Center, Durham, North Carolina"},{"name":"Department of Medicine, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"issue":"3","key":"2019053106102855500_B1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1749-6632.1951.tb31971.x","article-title":"Patterned loss of hair in man; types and incidence","volume":"53","author":"Hamilton","year":"1951","journal-title":"Ann N Y Acad Sci"},{"issue":"4170","key":"2019053106102855500_B2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1126\/science.186.4170.1213","article-title":"Steroid 5\u03b1-reductase deficiency in man: an inherited form of male pseudohermaphroditism","volume":"186","author":"Imperato-McGinley","year":"1974","journal-title":"Science"},{"key":"2019053106102855500_B3","author":"Carmina"},{"issue":"1","key":"2019053106102855500_B4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"issue":"11","key":"2019053106102855500_B5","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019053106102855500_B6","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019053106102855500_B7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"issue":"3","key":"2019053106102855500_B8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.1982.tb01732.x","article-title":"Low sex-hormone binding globulin levels in young women with diffuse hair loss","volume":"106","author":"Miller","year":"1982","journal-title":"Br J Dermatol"},{"issue":"5 Pt 1","key":"2019053106102855500_B9","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0190-9622(88)70241-8","article-title":"The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia","volume":"19","author":"Futterweit","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2019053106102855500_B10","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2001.117426","article-title":"Female pattern hair loss","volume":"45","author":"Olsen","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2019053106102855500_B11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2133.1999.03049.x","article-title":"Diffuse female hair loss: are androgens necessary","volume":"141","author":"Orme","year":"1999","journal-title":"Br J Dermatol"},{"issue":"5","key":"2019053106102855500_B12","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2133.2010.09661.x","article-title":"Female pattern hair loss in complete androgen insensitivity syndrome","volume":"162","author":"Cousen","year":"2010","journal-title":"Br J Dermatol"},{"issue":"5","key":"2019053106102855500_B13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1365-2230.2002.01085.x","article-title":"Female pattern hair loss","volume":"27","author":"Birch","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"2019053106102855500_B14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Evaluation and treatment of male and female pattern hair loss","volume":"52","author":"Olsen","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2019053106102855500_B15","first-page":"189","article-title":"Female pattern hair loss: current treatment concepts","volume":"2","author":"Dinh","year":"2007","journal-title":"Clin Interv Aging"},{"issue":"6","key":"2019053106102855500_B16","first-page":"348","article-title":"Developing clinical guidelines","volume":"170","author":"Shekelle","year":"1999","journal-title":"West J Med"},{"key":"2019053106102855500_B17","unstructured":"National Health and Medical Research Council . NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. Stage 2 consultation: early 2008\u2013end June 2009. Available at: www.mja.com.au\/sites\/default\/files\/NHMRC.levels.of.evidence.2008-09.pdf. Accessed 13 November 2018."},{"key":"2019053106102855500_B18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cct.2015.05.010","article-title":"Advances in the meta-analysis of heterogeneous clinical trials II: the quality effects model","volume":"45","author":"Doi","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"10","key":"2019053106102855500_B19","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"2019053106102855500_B20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"issue":"1","key":"2019053106102855500_B21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0190-9622(99)70539-6","article-title":"The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women","volume":"40","author":"Olsen","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2019053106102855500_B22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1067\/mjd.2003.81","article-title":"Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss","volume":"48","author":"Olsen","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"2019053106102855500_B23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A 20-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina","year":"2012","journal-title":"Obstet Gynecol"},{"key":"2019053106102855500_B24","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/jc.2013-2375","article-title":"Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause","volume":"98","author":"Welt","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019053106102855500_B25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1468-3083.2002.00475.x","article-title":"Psychological features of androgenetic alopecia","volume":"16","author":"Camacho","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7522","key":"2019053106102855500_B26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.331.7522.951","article-title":"The psychological impact of alopecia","volume":"331","author":"Hunt","year":"2005","journal-title":"BMJ"},{"issue":"11","key":"2019053106102855500_B27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11920-017-0834-2","article-title":"Depression and anxiety in polycystic ovary syndrome: etiology and treatment","volume":"19","author":"Cooney","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"5","key":"2019053106102855500_B28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen Excess\u2013Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil Steril"},{"issue":"1","key":"2019053106102855500_B29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2009.11.005","article-title":"Review of hair follicle dermal cells","volume":"57","author":"Yang","year":"2010","journal-title":"J Dermatol Sci"},{"issue":"8","key":"2019053106102855500_B30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.semcdb.2012.08.011","article-title":"Mesenchymal\u2013epithelial interactions during hair follicle morphogenesis and cycling","volume":"23","author":"Sennett","year":"2012","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"2019053106102855500_B31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.celrep.2018.06.084","article-title":"The mesenchymal niche of the hair follicle induces regeneration by releasing primed progenitors from inhibitory effects of quiescent stem cells","volume":"24","author":"Avigad Laron","year":"2018","journal-title":"Cell Reports"},{"issue":"1","key":"2019053106102855500_B32","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000081477","article-title":"Kenogen in female androgenetic alopecia. A longitudinal study","volume":"210","author":"Guarrera","year":"2005","journal-title":"Dermatology"},{"issue":"5","key":"2019053106102855500_B33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2006.07409.x","article-title":"Follicular miniaturization in female pattern hair loss: clinicopathological correlations","volume":"155","author":"Messenger","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"2019053106102855500_B34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/exd.13373","article-title":"Genetics and other factors in the aetiology of female pattern hair loss","volume":"26","author":"Redler","year":"2017","journal-title":"Exp Dermatol"},{"issue":"4","key":"2019053106102855500_B35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/exd.12965","article-title":"Hunting the genes in male-pattern alopecia: how important are they, how close are we and what will they tell us","volume":"25","author":"Heilmann-Heimbach","year":"2016","journal-title":"Exp Dermatol"},{"key":"2019053106102855500_B36","doi-asserted-by":"crossref","first-page":"14694","DOI":"10.1038\/ncomms14694","article-title":"Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness","volume":"8","author":"Heilmann-Heimbach","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"2019053106102855500_B37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/exd.12024","article-title":"Androgen actions on the human hair follicle: perspectives","volume":"22","author":"Inui","year":"2013","journal-title":"Exp Dermatol"},{"issue":"5","key":"2019053106102855500_B38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00403-018-1826-8","article-title":"Androgen modulation of Wnt\/\u03b2-catenin signaling in androgenetic alopecia","volume":"310","author":"Premanand","year":"2018","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"2019053106102855500_B39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1523-1747.ep12335779","article-title":"Different levels of 5\u03b1-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia","volume":"109","author":"Sawaya","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2019053106102855500_B40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1677\/joe.0.1560059","article-title":"Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp","volume":"156","author":"Hibberts","year":"1998","journal-title":"J Endocrinol"},{"issue":"1","key":"2019053106102855500_B41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00403-017-1798-0","article-title":"5\u03b1-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss","volume":"310","author":"S\u00e1nchez","year":"2018","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"2019053106102855500_B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.1990.tb03744.x","article-title":"Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia","volume":"32","author":"Montalto","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019053106102855500_B43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0015-0282(16)56999-4","article-title":"Alterations in androgen conjugate levels in women and men with alopecia","volume":"62","author":"Legro","year":"1994","journal-title":"Fertil Steril"},{"key":"2019053106102855500_B44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mce.2016.08.014","article-title":"A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids","volume":"441","author":"Pretorius","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2019053106102855500_B45","first-page":"1429","article-title":"Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women","volume":"80","author":"Zumoff","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019053106102855500_B46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/jid.1960.127","article-title":"Effect of pregnancy on the human hair cycle","volume":"35","author":"Lynfield","year":"1960","journal-title":"J Invest Dermatol"},{"issue":"10","key":"2019053106102855500_B47","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1634\/theoncologist.2013-0193","article-title":"Alopecia with endocrine therapies in patients with cancer","volume":"18","author":"Saggar","year":"2013","journal-title":"Oncologist"},{"issue":"2","key":"2019053106102855500_B48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.2009.09186.x","article-title":"Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss","volume":"161","author":"Yip","year":"2009","journal-title":"Br J Dermatol"},{"issue":"22","key":"2019053106102855500_B49","doi-asserted-by":"crossref","first-page":"12525","DOI":"10.1073\/pnas.93.22.12525","article-title":"An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation","volume":"93","author":"Oh","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019053106102855500_B50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2133.1992.tb00121.x","article-title":"Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis","volume":"127","author":"Jaworsky","year":"1992","journal-title":"Br J Dermatol"},{"issue":"12","key":"2019053106102855500_B51","first-page":"1404","article-title":"The role of inflammation and immunity in the pathogenesis of androgenetic alopecia","volume":"10","author":"Magro","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"2019053106102855500_B52","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000211447","article-title":"Pro-inflammatory cytokine cascade in human plucked hair","volume":"9","author":"Mah\u00e9","year":"1996","journal-title":"Skin Pharmacol"},{"issue":"6","key":"2019053106102855500_B53","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0190-9622(96)90113-9","article-title":"Chronic telogen effluvium: increased scalp hair shedding in middle-aged women","volume":"35","author":"Whiting","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2019053106102855500_B54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ics.12341","article-title":"Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflammation","volume":"38","author":"Ramos","year":"2016","journal-title":"Int J Cosmet Sci"},{"issue":"5","key":"2019053106102855500_B55","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2015.12.011","article-title":"Distinguishing diffuse alopecia areata (AA) from pattern hair loss (PHL) using CD3+ T cells","volume":"74","author":"Kolivras","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2019053106102855500_B56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/ijt.ijt_18_17","article-title":"Minoxidil downregulates interleukin-1 alpha gene expression in HaCaT cells","volume":"10","author":"Pekmezci","year":"2018","journal-title":"Int J Trichology"},{"issue":"126","key":"2019053106102855500_B57","doi-asserted-by":"crossref","first-page":"126ra34","DOI":"10.1126\/scitranslmed.3003122","article-title":"Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza","year":"2012","journal-title":"Sci Transl Med"},{"issue":"6","key":"2019053106102855500_B58","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2012.02.004","article-title":"Prostaglandins and chronic inflammation","volume":"33","author":"Aoki","year":"2012","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"2019053106102855500_B59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2133.2001.04018.x","article-title":"Hair density, hair diameter and the prevalence of female pattern hair loss","volume":"144","author":"Birch","year":"2001","journal-title":"Br J Dermatol"},{"issue":"1","key":"2019053106102855500_B60","first-page":"53","article-title":"Incidence of female androgenetic alopecia (female pattern alopecia)","volume":"27","author":"Norwood","year":"2001","journal-title":"Dermatol Surg"},{"issue":"3","key":"2019053106102855500_B61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1087-0024.2005.10102.x","article-title":"Prevalence of male and female pattern hair loss in Maryborough","volume":"10","author":"Gan","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"2019053106102855500_B62","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jaad.2012.09.046","article-title":"Factors associated with female pattern hair loss and its prevalence in Taiwanese women: a community-based survey","volume":"69","author":"Su","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2019053106102855500_B63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2001.04289.x","article-title":"The prevalence and types of androgenetic alopecia in Korean men and women","volume":"145","author":"Paik","year":"2001","journal-title":"Br J Dermatol"},{"issue":"4","key":"2019053106102855500_B64","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2133.2010.09640.x","article-title":"Prevalence of androgenetic alopecia in China: a community-based study in six cities","volume":"162","author":"Wang","year":"2010","journal-title":"Br J Dermatol"},{"issue":"6","key":"2019053106102855500_B65","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"2019053106102855500_B66","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s004030000184","article-title":"Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism","volume":"292","author":"Vexiau","year":"2000","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"2019053106102855500_B67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/md.0b013e3181946a2c","article-title":"Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism","volume":"88","author":"Karrer-Voegeli","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"2019053106102855500_B68","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2015.06.063","article-title":"Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy","volume":"73","author":"Famenini","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2019053106102855500_B69","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.1989.tb00446.x","article-title":"Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients","volume":"30","author":"Conway","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019053106102855500_B70","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019053106102855500_B71","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019053106102855500_B72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/00016340903353284","article-title":"Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism","volume":"89","author":"\u00d6zdemir","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2019053106102855500_B73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fertnstert.2013.03.010","article-title":"Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross-sectional study","volume":"100","author":"Wang","year":"2013","journal-title":"Fertil Steril"},{"issue":"4","key":"2019053106102855500_B74","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.fertnstert.2014.01.003","article-title":"Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features","volume":"101","author":"Quinn","year":"2014","journal-title":"Fertil Steril"},{"issue":"4","key":"2019053106102855500_B75","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/0019-5154.160505","article-title":"Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: a cross-sectional study clinical study","volume":"60","author":"Gowri","year":"2015","journal-title":"Indian J Dermatol"},{"issue":"1","key":"2019053106102855500_B76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/jdv.12432","article-title":"Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients","volume":"29","author":"Hong","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"2019053106102855500_B77","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/jog.12945","article-title":"Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome","volume":"42","author":"Leerasiri","year":"2016","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"2019053106102855500_B78","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamadermatol.2015.4498","article-title":"Cutaneous findings and systemic associations in women with polycystic ovary syndrome","volume":"152","author":"Schmidt","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"3","key":"2019053106102855500_B79","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/jocd.12387","article-title":"Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China","volume":"17","author":"Feng","year":"2018","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"2019053106102855500_B80","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/2229-5178.202275","article-title":"Cutaneous manifestations of polycystic ovary syndrome: a cross-sectional clinical study","volume":"8","author":"Keen","year":"2017","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"2019053106102855500_B81","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.0007-0963.2003.05809.x","article-title":"Women who present with female pattern hair loss tend to underestimate the severity of their hair loss","volume":"150","author":"Biondo","year":"2004","journal-title":"Br J Dermatol"},{"issue":"4","key":"2019053106102855500_B82","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/jdv.13455","article-title":"Towards a consensus on how to diagnose and quantify female pattern hair loss\u2014the \u201cFemale Pattern Hair Loss Severity Index (FPHL-SI)\u201d","volume":"30","author":"Harries","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2019053106102855500_B83","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4103\/0974-7753.58554","article-title":"Reliability of Hamilton-Norwood classification","volume":"1","author":"Guarrera","year":"2009","journal-title":"Int J Trichology"},{"key":"2019053106102855500_B84","first-page":"59","volume-title":"Disorders of Hair Growth: Diagnosis and Treatment","author":"Olsen","year":"1994"},{"issue":"3","key":"2019053106102855500_B85","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.jidsp.5640230","article-title":"Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women","volume":"4","author":"Whiting","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"3","key":"2019053106102855500_B86","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1067\/mjd.2001.117428","article-title":"Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss","volume":"45","author":"Whiting","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"2019053106102855500_B87","author":"Olsen"},{"issue":"2","key":"2019053106102855500_B88","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/0974-7753.58555","article-title":"Dermoscopy in female androgenic alopecia: method standardization and diagnostic criteria","volume":"1","author":"Rakowska","year":"2009","journal-title":"Int J Trichology"},{"issue":"10","key":"2019053106102855500_B89","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00403-003-0447-y","article-title":"Histological features of peripilar signs associated with androgenetic alopecia","volume":"295","author":"Deloche","year":"2004","journal-title":"Arch Dermatol Res"},{"issue":"5 Pt 1","key":"2019053106102855500_B90","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0190-9622(93)70106-4","article-title":"Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia","volume":"28","author":"Whiting","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"2019053106102855500_B91","first-page":"165","article-title":"The value of horizontal sections of scalp biopsies","volume":"1","author":"Whiting","year":"1990","journal-title":"J Cut Aging and Cosmetic Dermatol"},{"issue":"6","key":"2019053106102855500_B92","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/archderm.135.6.656","article-title":"Hair density in African Americans","volume":"135","author":"Sperling","year":"1999","journal-title":"Arch Dermatol"},{"issue":"2","key":"2019053106102855500_B93","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1067\/mjd.2002.119558","article-title":"Hair counts from scalp biopsy specimens in Asians","volume":"46","author":"Lee","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2019053106102855500_B94","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0738-081X(88)90074-0","article-title":"The comparative histopathology of male-pattern baldness and senescent baldness","volume":"6","author":"Kligman","year":"1988","journal-title":"Clin Dermatol"},{"key":"2019053106102855500_B95","first-page":"24","article-title":"Scalp biopsy as a diagnostic and prognostic tool in androgenetic alopecia","volume":"8","author":"Whiting","year":"1998","journal-title":"Derm Ther"},{"issue":"10","key":"2019053106102855500_B96","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archderm.141.10.1243","article-title":"Distinguishing androgenetic alopecia from chronic telogen effluvium when associated in the same patient: a simple noninvasive method","volume":"141","author":"Rebora","year":"2005","journal-title":"Arch Dermatol"},{"key":"2019053106102855500_B97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1067\/mjd.2003.68","article-title":"Summary of North American Hair Research Society (NAHRS)-sponsored workshop on cicatricial alopecia, Duke University Medical Center, February 10 and 11, 2001","volume":"48","author":"Olsen","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2019053106102855500_B98","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaad.2009.11.693","article-title":"Central hair loss in African American women: incidence and potential risk factors","volume":"64","author":"Olsen","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2019053106102855500_B99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1087-0024.2005.10109.x","article-title":"Female pattern hair loss and its relationship to permanent\/cicatricial alopecia: a new perspective","volume":"10","author":"Olsen","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6","key":"2019053106102855500_B100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archderm.1994.01690060100013","article-title":"Post-menopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution","volume":"130","author":"Kossard","year":"1994","journal-title":"Arch Dermatol"},{"issue":"2","key":"2019053106102855500_B101","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archderm.136.2.205","article-title":"Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern","volume":"136","author":"Zinkernagel","year":"2000","journal-title":"Arch Dermatol"},{"key":"2019053106102855500_B102","author":"Carmina"},{"issue":"6","key":"2019053106102855500_B103","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.steroids.2009.01.004","article-title":"Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods [published correction appears in Steroids. 2009 Sep;74(9):791]","volume":"74","author":"Vesper","year":"2009","journal-title":"Steroids"},{"issue":"4","key":"2019053106102855500_B104","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/00365513.2014.942694","article-title":"Sensitive RIA measures testosterone concentrations in prepubertal and pubertal children comparable to tandem mass spectrometry","volume":"75","author":"Ankarberg-Lindgren","year":"2015","journal-title":"Scand J Clin Lab Invest"},{"key":"2019053106102855500_B105","unstructured":"Centers for Disease Control and Prevention. CDC Hormone Standardization Program (CDC HoSt). Certified Total Testosterone Procedures. Available at: www.cdc.gov\/labstandards\/pdf\/hs\/CDC_Certified_Testosterone_Procedures-508.pdf. Accessed 6 March 2019."},{"issue":"4","key":"2019053106102855500_B106","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A reappraisal of testosterone\u2019s binding in circulation: physiological and clinical implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"issue":"6","key":"2019053106102855500_B107","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1210\/jcem.82.6.9999","article-title":"Errors in the measurement of plasma free testosterone","volume":"82","author":"Rosner","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019053106102855500_B108","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1210\/jcem.86.6.7643","article-title":"An extraordinarily inaccurate assay for free testosterone is still with us","volume":"86","author":"Rosner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019053106102855500_B109","author":"Siah"},{"key":"2019053106102855500_B110","first-page":"w14058","article-title":"Subclinical hypothyroidism: summary of evidence in 2014","volume":"144","author":"Baumgartner","year":"2014","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"2019053106102855500_B111","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2230.2002.01076.x","article-title":"Nutritional factors and hair loss","volume":"27","author":"Rushton","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"2019053106102855500_B112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5826\/dpc.0701a01","article-title":"Diet and hair loss: effects of nutrient deficiency and supplement use","volume":"7","author":"Guo","year":"2017","journal-title":"Dermatol Pract Concept"},{"issue":"6","key":"2019053106102855500_B113","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3346\/jkms.2013.28.6.934","article-title":"Iron plays a certain role in patterned hair loss","volume":"28","author":"Park","year":"2013","journal-title":"J Korean Med Sci"},{"issue":"5","key":"2019053106102855500_B114","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1523-1747.2003.12540.x","article-title":"Decreased serum ferritin is associated with alopecia in women","volume":"121","author":"Kantor","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2019053106102855500_B115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2009.12.006","article-title":"Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups","volume":"63","author":"Olsen","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2019053106102855500_B116","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000346698","article-title":"Serum ferritin and vitamin d in female hair loss: do they play a role","volume":"26","author":"Rasheed","year":"2013","journal-title":"Skin Pharmacol Physiol"},{"issue":"3","key":"2019053106102855500_B117","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0974-7753.188965","article-title":"Serum vitamin D3 level in patients with female pattern hair loss","volume":"8","author":"Banihashemi","year":"2016","journal-title":"Int J Trichology"},{"issue":"4","key":"2019053106102855500_B118","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5021\/ad.2013.25.4.405","article-title":"Analysis of serum zinc and copper concentrations in hair loss","volume":"25","author":"Kil","year":"2013","journal-title":"Ann Dermatol"},{"issue":"5","key":"2019053106102855500_B119","first-page":"CD007628","article-title":"Interventions for female pattern hair loss","author":"van Zuuren","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2019053106102855500_B120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br J Dermatol"},{"issue":"4","key":"2019053106102855500_B121","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2019053106102855500_B122","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2019053106102855500_B123","first-page":"883","article-title":"Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss: a phase III, randomized, investigator-blinded study","volume":"15","author":"Blume-Peytavi","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"8","key":"2019053106102855500_B124","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archderm.135.8.989","article-title":"Finasteride, 1 mg (Propecia), is the optimal dose for the treatment of men with male pattern hair loss","volume":"135","author":"Kaufman","year":"1999","journal-title":"Arch Dermatol"},{"issue":"3","key":"2019053106102855500_B125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40257-014-0077-5","article-title":"Androgenetic alopecia: an evidence-based treatment update","volume":"15","author":"Varothai","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"5 Pt 1","key":"2019053106102855500_B126","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2019053106102855500_B127","doi-asserted-by":"crossref","first-page":"e12588","DOI":"10.1111\/dth.12588","article-title":"Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg\/day in women with female pattern hair loss","volume":"31","author":"Won","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"3","key":"2019053106102855500_B128","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000079890","article-title":"Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women","volume":"209","author":"Tr\u00fceb","year":"2004","journal-title":"Dermatology"},{"issue":"2","key":"2019053106102855500_B129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1468-3083.2010.03758.x","article-title":"5 mg\/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss","volume":"25","author":"Yeon","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2019053106102855500_B130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0974-7753.114709","article-title":"Finasteride 5 mg\/day treatment of patterned hair loss in normo-androgenetic postmenopausal women","volume":"5","author":"Oliveira-Soares","year":"2013","journal-title":"Int J Trichology"},{"issue":"6","key":"2019053106102855500_B131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/0378-6323.144162","article-title":"The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia","volume":"80","author":"Boersma","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"2019053106102855500_B132","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(02)04551-X","article-title":"Treatment of hyperandrogenic alopecia in women","volume":"79","author":"Carmina","year":"2003","journal-title":"Fertil Steril"},{"issue":"5","key":"2019053106102855500_B133","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1067\/mjd.2002.124608","article-title":"Hair loss in women with hyperandrogenism: four cases responding to finasteride","volume":"47","author":"Shum","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2019053106102855500_B134","first-page":"488","article-title":"Female androgenetic alopecia treated by finasteride: a case forward","volume":"84","author":"Valsecchi","year":"2004","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"2019053106102855500_B135","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5\u03b1-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride","volume":"55","author":"Olsen","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2019053106102855500_B136","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1574884712666170310111125","article-title":"Dutasteride in androgenetic alopecia: an update","volume":"12","author":"Arif","year":"2017","journal-title":"Curr Clin Pharmacol"},{"issue":"1","key":"2019053106102855500_B137","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijwd.2017.01.001","article-title":"Hormonal therapy in female pattern hair loss","volume":"3","author":"Brough","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"3","key":"2019053106102855500_B138","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"2019053106102855500_B139","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1345\/aph.1P600","article-title":"Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss","volume":"45","author":"Paradisi","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2019053106102855500_B140","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"issue":"1","key":"2019053106102855500_B141","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/lsm.22512","article-title":"Low-level laser therapy as a treatment for androgenetic alopecia","volume":"49","author":"Afifi","year":"2017","journal-title":"Lasers Surg Med"},{"issue":"8","key":"2019053106102855500_B142","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/dsu.12200","article-title":"Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device\u2013controlled multicenter trial","volume":"39","author":"Kim","year":"2013","journal-title":"Dermatol Surg"},{"issue":"2","key":"2019053106102855500_B143","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study","volume":"15","author":"Jimenez","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"2019053106102855500_B144","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/lsm.22170","article-title":"Low-level laser (light) therapy (LLLT) for treatment of hair loss","volume":"46","author":"Avci","year":"2014","journal-title":"Lasers Surg Med"},{"issue":"2","key":"2019053106102855500_B145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/14764170902842531","article-title":"The use of low-level light for hair growth: part I","volume":"11","author":"Avram","year":"2009","journal-title":"J Cosmet Laser Ther"},{"issue":"5","key":"2019053106102855500_B146","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tibtech.2006.02.010","article-title":"New insights into and novel applications for platelet-rich fibrin therapies","volume":"24","author":"Anitua","year":"2006","journal-title":"Trends Biotechnol"},{"issue":"1","key":"2019053106102855500_B147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijt.ijt_74_16","article-title":"A meta-analysis on evidence of platelet-rich plasma for androgenetic alopecia","volume":"10","author":"Giordano","year":"2018","journal-title":"Int J Trichology"},{"issue":"5","key":"2019053106102855500_B148","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0190-9622(03)01568-8","article-title":"Hair transplanting: an important but often forgotten treatment for female pattern hair loss","volume":"49","author":"Unger","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2019053106102855500_B149","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000017954","article-title":"Ketoconazole shampoo: effect of long-term use in androgenic alopecia","volume":"196","author":"Pi\u00e9rard-Franchimont","year":"1998","journal-title":"Dermatology"},{"issue":"1","key":"2019053106102855500_B150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jdermsci.2006.08.011","article-title":"Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity","volume":"45","author":"Inui","year":"2007","journal-title":"J Dermatol Sci"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/7\/2875\/28744941\/jc.2018-02548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T16:05:54Z","timestamp":1574006754000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/7\/2875\/5342938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":150,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,2,20]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-02548","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735131710.793560864","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,2,20]]}}}